Boehringer Ingelheim once again invites public and private researchers studying equine infectious diseases to submit proposals for the 2017 Equine Research Awards.
“With our continued focus on prevention, BI is dedicated to supporting equine research proposals which focus on identifying preventative methods and new disease treatment,” said Steve Grubbs, DVM, PhD, DACVIM, the BI equine technical manager. “Over the last six years we’ve helped fund 30 research proposals. This program has continued to support the equine industry and demonstrate our commitment to helping advance the understanding, diagnosis and prevention of equine diseases."
Proposals must address the following focus areas for consideration:· Practical application and ability to improve the diagnosis, pathogenesis, transmission, control and/or prevention of equine infectious disease(s)· Disease(s) can be bacterial or viral etiologiesVeterinarians, diagnosticians, public and private researchers in the United States and Canada are eligible to submit proposals for research programs that help advance the diagnosis, treatment and understanding of equine infectious diseases.
BI will give a total of $75,000 in five individual $15,000 awards to fund selected studies.
Proposals must be submitted by September 15, 2017, and they will be reviewed by an independent equine research review board composed of industry professionals, including practicing equine veterinarians and researchers. Awards will be determined based on established criteria, including potential impact on the equine industry; originality and scientific quality; and probability of success in completing the yearlong studies.
The awards will be announced during the 2017 American Association of Equine Practitioners Annual Convention in San Antonio, Texas.
To participate in the research awards program, submit a proposal, cover letter, curriculum vitae and two letters of recommendation by September 15, 2017, to: Boehringer Ingelheim Attn: Steve Grubbs, DVM, PhD, DACVIM, The Advancement in Equine Research Award, 3902 Gene Field Road, St. Joseph, MO 64506 USA.
The BI Equine Research Awards were launched in 2011 to support veterinary research that results in practical applications for or insights into important equine infectious diseases and improves the quality of life for all horses. More than $375,000 has been awarded to date for research into these diseases, which include equine influenza, equine rhinitis virus, coronavirus and equine inflammatory airway diseases.For more information and complete submission instructions, please visit us at www.equinediseaseresearch.com.
About Boehringer Ingelheim Animal Health
As the second largest animal health business in the world, Boehringer Ingelheim is committed to improving animal health. With more than 10,000 employees worldwide, Boehringer Ingelheim Animal Health has products available in more than 150 markets and a global presence in 99 countries. For more information about Boehringer Ingelheim Animal Health, click here.
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the industry’s top 20 pharmaceutical companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects, such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees’ different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.
More information about Boehringer Ingelheim can be found on www.boehringer-ingelheim.com or in our annual report: http://annualreport.boehringer-ingelheim.com.